Kidpik Corp.

Kidpik Corp.

PIK
Kidpik Corp.US flagNASDAQ Capital Market
2.38
USD
+2.38
- -
4.76MMarket Cap
Kidpik Corp.
PIK
(NASDAQ Capital Market)

Recent

price

2.38

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
TTM
FRC
8.87
11.12
19.33
10.75
8.68
4.03
Revenue per Share
-3.02
-2.75
-5.26
-4.97
-6.04
-4.12
Basic EPS, GAAP
-2.77
-2.34
-9.79
-4.37
-0.24
-0.77
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
-15.61
-18.36
-30.02
-27.1
-31.36
-28.68
Book Value per Share
-0.08
1.17
13.05
5.71
0.63
-1.28
Tangible Book Value per Share
2
2
1
2
2
2
Basic Weighted Avg Shares
14
17
22
16
14
8
Sales/Revenue/Turnover
-30.28
-21.64
-25.94
-47.48
-69.55
-101.78
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Depreciation Expense
-5
-4
-6
-8
-10
-8
Net Income, GAAP
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-34.05
-24.73
-27.24
-46.21
-69.56
-102.25
Profit Margin (%)
3
2
15
8
1
-3
Working Capital
3
- -
- -
1
1
1
LT Debt
- -
2
15
9
1
-2
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
ST Debt
2
2
3
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
8
5
4

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
Total Current Assets
5
5
4
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
4
4
3
Total Current Liabilities
6
7
7
Payables & Accruals
4
4
4
ST Debt
2
2
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-88.15%
Free Cash Flow
- -
- -
-94.03%
Net Income, GAAP
- -
- -
30.08%
Sales/Revenue/Turnover
- -
- -
-13.58%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
4
4
4
5
16
2023
4
3
3
3
14
2024
2
1
1
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-1.19
-1.03
-1.59
-1.17
-4.97
2023
-1.27
-1.31
-1.2
- -
-6.04
2024
-0.94
-0.67
-0.45
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Business
Kidpik Corp. (Nasdaq: PIK) operates as a subscription-based e-commerce platform specializing in personalized kids' clothing boxes that deliver curated, mix-and-match outfits including apparel, footwear, and accessories for children aged 3 to 16; the service features a try-before-you-buy model where customers pay only for kept items with free styling, shipping, and returns, complemented by an e-commerce store for a la carte purchases. Founded in 2016 and headquartered in New York City, the company designs in-house collections leveraging over three decades of childrenswear expertise from founders including CEO Ezra Dabah, targeting busy parents seeking convenient, high-quality, trend-conscious fashion that empowers kids' personal style and confidence across the United States. Core offerings encompass seasonal subscription boxes with coordinated tops, bottoms, dresses, shoes, and accessories in sizes from 12 months to 16, including husky/slim fits and private label brands; the platform uses style quizzes, data analytics, and stylist input to personalize over 1.3 million boxes shipped to date. In recent developments, Kidpik entered a definitive merger agreement in April 2024 with Nina Footwear Corp., anticipating closure in the first quarter of 2025 under the new Nasdaq ticker NINA to boost revenue, cash flow, and stockholder value while retaining $43 million in net operating loss carryforwards; the company ceased subscription marketing and new inventory purchases to clear existing stock ahead of the combination, reported third quarter 2024 financial results in November 2024, and regained Nasdaq minimum bid price compliance in March 2024.

Company News

APIChat
  • Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies

  • Private Credit: Trying To Count The Cockroaches

  • HTGC 2-WEEK DEADLINE ALERT: Hercules Capital (HTGC) Facing Securities Class Action After Allegations of Copying Google Ventures, Misstated Marks, and PIK Loans - Hagens Berman

  • Hercules Capital (HTGC) Under Fire: Class Action Filed After Allegations of Copying Google Ventures, Misstated Marks, and PIK Loans -- Hagens Berman

  • Hercules Capital (HTGC) Under Fire: Class Action Filed After Allegations of Copying Google Ventures, Misstated Marks, and PIK Loans -- Hagens Berman

  • Hercules Capital (HTGC) Under Fire: Class Action Filed After Allegations of Copying Google Ventures, Misstated Marks, and PIK Loans -- Hagens Berman

  • Hercules Capital (HTGC) Under Fire: Class Action Filed After Allegations of Copying Google Ventures, Misstated Marks, and PIK Loans -- Hagens Berman

  • Hercules Capital (HTGC) Under Fire: Class Action Filed After Allegations of Copying Google Ventures, Misstated Marks, and PIK Loans -- Hagens Berman

  • Hercules Capital (HTGC) Under Fire: Class Action Filed After Allegations of Copying Google Ventures, Misstated Marks, and PIK Loans -- Hagens Berman

  • Hercules Capital (HTGC) Under Fire: Class Action Filed After Allegations of Copying Google Ventures, Misstated Marks, and PIK Loans -- Hagens Berman

  • Hercules Capital (HTGC) Under Fire: Class Action Filed After Allegations of Copying Google Ventures, Misstated Marks, and PIK Loans -- Hagens Berman

  • Hercules Capital (HTGC) Under Fire: Class Action Filed After Allegations of Copying Google Ventures, Misstated Marks, and PIK Loans -- Hagens Berman

  • Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer

  • Detailed Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Presented at 2025 ESMO Congress Demonstrate Potential for Gedatolisib Regimens to be Practice Changing for Patients with HR+/HER2- Advanced Breast Cancer

  • Oatly Announces Issuance of SEK 1,700 million Nordic Bonds, Entry into SEK 750 million Super Senior Revolving Credit Facility and Intention to Complete Prepayment of Term Loan B, as well as Repurchase and Cancellation of Certain Convertible Senior PIK Notes due 2028

  • Hercules Capital: Growing Troubles Within Portfolio Warrants Caution

  • Prospect Capital: PIK Drop A Problem, But Dividend Should Be Safe

  • Kidpik Announces Suspension of Trading of Common Stock on Nasdaq and its Intention to Appeal

  • Hertz Announces Receipt of Requisite Consents from Holders to Amend its 12.625% First Lien Senior Secured Notes Due 2029 and 8.000% Exchangeable Senior Second-Lien PIK Notes due 2029 and Expiration of Consent Solicitations

  • Hertz Announces Consent Solicitations to Amend its 12.625% First Lien Senior Secured Notes Due 2029 and 8.000% Exchangeable Senior Second-Lien PIK Notes due 2029